Tacrolimus recalls
The FDA has published 15 recalls involving Tacrolimus since 2012. The latest was reported on 5 Feb 2025. Aidapak Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls15since 2012
Last 12 months0reported
Class I213% of total
Ongoing5latest 5 Feb 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 13%Class II 10 67%Class III 3 20%
Why tacrolimus is recalled
Companies
Brands
By year
Ongoing tacrolimus recalls
5 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Astagraf XL (tacrolimus extended-release capsules) 0.5 mg recalledAstagraf Xl | Astellas Pharma US | Packaging Defects | Nationwide |
| Drug | CLASS I | Prograf (tacrolimus) capsules, USP, 0.5 mg recalledPrograf | Astellas Pharma US | Packaging Defects | Nationwide |
| Drug | CLASS II | Tacrolimus Capsules, USP, 0.5 mg recalled by Dr. Reddy's LaboratoriesTacrolimus | Dr. Reddy's Laboratories | Other | Nationwide |
| Drug | CLASS III | Tacrolimus Ointment, 0.1%, For Dermatological Use Only recalledTacrolimus | Glenmark Pharmaceuticals Inc., USA | Other | Nationwide |
| Drug | CLASS II | Tacrolimus (0.02% and 0.03%) drops recalled by Lowlite Investments | Lowlite Investments | Sterility | Nationwide |
All tacrolimus recalls, newest first
15 totalShould you stop taking Tacrolimus?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.